Ernest B.
- Country
- Croatia
- Department
- Department of pediatric hematology and oncology
Research Overview
- Evaluation of PEGaspargase and Rituximab in Pediatric Non-Mature-B Acute Lymphoblastic Leukemia: A Randomized Clinical Trial
- An 18-month low-interventional prospective, multicentre study to assess joint outcomes in patients with haemophilia A or B on prophylaxis with efmoroctocog alfa or eftrenonacog alfa
Data & Insights
Has run more than one trial at 2 of 57 partner sites.
Specializations
Hematologic Oncology
This investigator specializes in treating Diffuse Large B-Cell Lymphoma (DLBCL), conducting research on novel therapeutic approaches including combination treatments with epcoritamab and established protocols.
- Relapsed/Refractory DLBCL Management
- First-line DLBCL Treatment
Hematologic Disorders
Focuses on treating hemophilia A and B, investigating novel prophylactic treatments and evaluating joint outcomes in patients using various therapeutic agents.
- Hemophilia Treatment Innovation
- Joint Status Assessment
Inflammatory Conditions
Conducts research in multiple inflammatory disorders including Hidradenitis Suppurativa, Alopecia Areata, and various inflammatory bowel conditions.
- Crohn's Disease Management
- Ulcerative Colitis Treatment
- Dermatological Conditions
Myeloproliferative Disorders
Investigates treatments for Myeloproliferative Neoplasms and Myelofibrosis, exploring combination therapies and novel therapeutic approaches.
- Targeted Therapy Development
- Treatment Safety Assessment
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.